Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Designation is based on positive results from the HERCULES study in adults ...

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and ...

Pivotal phase 3 data show rapid and durable platelet response, reduced bleeding and need for rescue response, and improved physical fatigue and quality of life measures in patients with persistent or ...

Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare) to CD&R, the financial information ...

Autoimmune type 1 diabetes (T1D) is an autoimmune progressive and lifelong condition that can develop regardless of age, lifestyle or family history. Individuals with autoimmune T1D are typically ...

Stigma and Misunderstanding: Many people still hold misconceptions about epilepsy, leading to stigma and discrimination. Seizure Management: The unpredictability of seizures can affect activities, ...

Recommendation based on IMROZ phase 3 study demonstrating Sarclisa in combination with VRd significantly improved progression-free survival, compared to standard-of-care VRd alone If approved, ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the US suffer from chronic spontaneous urticaria (CSU) that is ...

Although presymptomatic T1D (Stages 1 and 2) can be detected months or years before symptoms appear, most people are not diagnosed until they feel unwel. 10 11 Over the past 50 years, scientists ...

AI is an incredibly powerful tool that can empower complex data analysis and decision-making. To fully leverage the capabilities of AI, transparency and explainability are required to provide ...

La transparence et l'explicabilité désignent l'idée que toutes les parties prenantes affectées par le résultat d'un système d'IA devraient pleinement comprendre le fonctionnement interne de ce système ...

Ce communiqué contient des déclarations prospectives. Ces déclarations ne constituent pas des faits historiques. Ces déclarations comprennent des projections et des estimations ainsi que les ...